In 57 chronic hemodialysis patients enrolled in a randomized crossover trial comparing paricalcitol and alfacalcidol , we examined the changes in osteoprotegerin , fetuin-A , NT-proBNP , hs-Crp , IL-6 and TNF - , during 16weeks of treatment .